Amanda T. McCleish - Concepedia

Author

Amanda T. McCleish

The University of Texas Health Science Center at San Antonio

Also Known As

A T McCleish, Amanda T. McCleish, Amanda T. Mccleish

Publications

742

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Cleveland Clinic University of Utah Stanford University Nationwide Children's Hospital

About

Amanda T. McCleish is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	513
2	Cell Biology	3	3	232
3	Engineering	2	2	176
4	Allergy	1	1	44
5	Biomedical Engineering	1	1	132

Amanda T. McCleish

Publications

738

Citations

H-Index

Page 1

	Year	Citations
Evidence for an Unanticipated Relationship between Undifferentiated Pleomorphic Sarcoma and Embryonal Rhabdomyosarcoma Brian P. Rubin, Koichi Nishijo, Hung-I Harry Chen, Cancer Cell Unanticipated RelationshipTumoral PathologyMalignant DiseaseSurgical PathologyPathology	2011	187
Biomarker system for studying muscle, stem cells, and cancer <i>in vivo</i> Koichi Nishijo, Tohru Hosoyama, Christopher R.R. Bjornson, The FASEB Journal EngineeringMuscle Satellite CellsBiomedical EngineeringBiomarker SystemStem Cell Biology	2009	132
Lineage of origin in rhabdomyosarcoma informs pharmacological response Jinu Abraham, Yaiza Núñez‐Álvarez, Simone Hettmer, Genes & Development	2014	103
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma E Taniguchi, Koichi Nishijo, Amanda T. McCleish, Oncogene PathologyCancer TreatmentMedicineTumor BiologyAlveolar Rhabdomyosarcoma	2008	94
Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma Koichi Nishijo, Qingrong Chen, Lei Zhang, Cancer Research	2009	88
Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo, Molecular Cancer Therapeutics Igf1r Inhibitor ResistanceMedicineReceptor Tyrosine KinaseHer2 Inhibitor LapatinibEvasion Mechanisms	2011	56
Immune Competency of a <i>Hairless</i> Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice Beverly S. Schaffer, Mitchell H. Grayson, Joy M. Wortham, Molecular Cancer Therapeutics EngineeringTransgenic Mouse ModelsImmune RegulationImmunologyImmunodominance	2010	44
Bortezomib reverses a post‐translational mechanism of tumorigenesis for <i>patched1</i> haploinsufficiency in medulloblastoma Eri Taniguchi, Min Jung Cho, Benjamin R. Arenkiel, Pediatric Blood & Cancer	2009	34

Page 1